Unresolved issues of anticoagulation in atrial fibrillation: age, BMI, reduced dose, and ethnicity

被引：3
|
作者：
Luscher, Thomas F. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Imperial Coll, Cardiol, London, England
[2] Royal Brompton Hosp, Res Educ & Dev, London, England
[3] Harefield Hosp London, London, England
[4] Univ Zurich, Ctr Mol Cardiol, Zurich, Switzerland
[5] Zurich Heart House, EHJ Editorial Off, Hottingerst 14, CH-8032 Zurich, Switzerland
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷 / 19期
关键词：
ORAL ANTICOAGULANTS; MANAGEMENT; STROKE; EVENTS;
D O I：
10.1093/eurheartj/ehz302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1477 / 1481
页数：5
相关论文
共 50 条
  • [21] Age threshold for anticoagulation in patients with atrial fibrillation: A Swedish nationwide observational study
    Andersson, Tommy
    Aspberg, Sara
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 326 : 92 - 97
  • [22] Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function
    Bonde, A. Nissen
    Lip, G. Y. H.
    Kamper, A. L.
    Staerk, L.
    Torp-Pedersen, C.
    Gislason, G.
    Olesen, J. B.
    EUROPEAN HEART JOURNAL, 2016, 37 : 499 - 500
  • [23] Reduced dementia risk in patients with optimized anticoagulation therapy undergoing atrial fibrillation ablation
    Akerstrom, Finn
    Charitakis, Emmanouil
    Paul-Nordin, Astrid
    Braunschweig, Frieder
    Friberg, Leif
    Tabrizi, Fariborz
    Jensen-Urstad, Mats
    Drca, Nikola
    HEART RHYTHM, 2024, 21 (09) : 1487 - 1492
  • [24] Age, Ethnicity, and Stroke Risk in Patients With Atrial Fibrillation Another Stitch in the Patchwork
    Savino, John A., III
    Halperin, Jonathan L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (12) : 1348 - 1349
  • [25] Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation
    Inohara, Taku
    Holmes, DaJuanicia N.
    Pieper, Karen
    Blanco, Rosalia G.
    Allen, Larry A.
    Fonarow, Gregg C.
    Gersh, Bernard J.
    Hylek, Elaine M.
    Ezekowitz, Michael D.
    Kowey, Peter R.
    Reiffel, James A.
    Naccarelli, Gerald V.
    Chan, Paul S.
    Mahaffey, Kenneth W.
    Singer, Daniel E.
    Freeman, James V.
    Steinberg, Benjamin A.
    Peterson, Eric D.
    Piccini, Jonathan P.
    HEART, 2020, 106 (05) : 358 - 364
  • [26] Reduced Dose Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation
    Zuo, Silu
    Chen, Billy
    Kataruka, Akash
    Bell, Sean M.
    CURRENT GERIATRICS REPORTS, 2019, 8 (01) : 43 - 48
  • [27] Reduced Dose Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation
    Silu Zuo
    Billy Chen
    Akash Kataruka
    Sean M. Bell
    Current Geriatrics Reports, 2019, 8 : 43 - 48
  • [28] Reduced NOAK dose in atrial fibrillation: efficacy and safety compared with warfarin
    Amadori, Kerstin
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2017, 50 (07): : 639 - 640
  • [29] Anticoagulation in the case of atrial fibrillation:: what is the well tolerated and efficient dose to reduce the risk of stroke?
    Mahé, I
    PRESSE MEDICALE, 2004, 33 (05): : 295 - 295
  • [30] Age Criteria is Necessary for the Dose Reduction of Rivaroxaban in Patients With Atrial Fibrillation?
    Lee, Ki Hong
    Yoon, Namsik
    CIRCULATION, 2019, 140
12345